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Background: Over the years, there has been a strong consensus in dentistry that at least two implants are required
to retain a complete mandibular denture. It has been shown in several clinical trials that one single median implant
can retain a mandibular overdenture sufficiently well for up to 5 years without implant failures, when delayed
loading was used. However, other trials have reported conflicting results with in part considerable failure rates
when immediate loading was applied. Therefore it is the purpose of the current randomized clinical trial to test the
hypothesis that immediate loading of a single mandibular midline implant with an overdenture will result in a
comparable clinical outcome as using the standard protocol of delayed loading.
Methods/design: This prospective nine-center randomized controlled clinical trial is still ongoing. The final patient
will complete the trial in 2016. In total, 180 edentulous patients between 60 and 89 years with sufficient complete
dentures will receive one median implant in the edentulous mandible, which will retain the existing complete
denture using a ball attachment. Loading of the median implant is either immediately after implant placement
(experimental group) or delayed by 3 months of submerged healing at second-stage surgery (control group).
Follow-up of patients will be performed for 24 months after implant loading. The primary outcome measure is
non-inferiority of implant success rate of the experimental group compared to the control group. The secondary
outcome measures encompass clinical, technical and subjective variables. The study was funded by the Deutsche
Forschungsgemeinschaft (German research foundation, KE 477/8-1).
Discussion: This multi-center clinical trial will give information on the ability of a single median implant to retain a
complete mandibular denture when immediately loaded. If viable, this treatment option will strongly improve
everyday dental practice.
Trial registration: The trial has been registered at Deutsches Register Klinischer Studien (German register of clinical
trials) under DRKS-ID: DRKS00003730 since 23 August 2012. (www.germanctr.de).
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Edentulism still occurs in elderly people in Germany and
all over the world. In Germany, 30.5% of the population
between 65 and 74 years are edentulous in the maxilla
and/or mandible and 22.5% are completely edentulous
[1]. Over the years there has been a strong consensus in
dentistry that at least two implants are required to retain
a complete denture in the edentulous mandible [2,3]. In-
deed, two implants in the interforaminal area have high
implant success rates and improve masticatory function
[4-6]. In addition, a systematic review on the standard
care for an edentulous mandible concluded that there is
no strong evidence supporting a single standard of care
for the edentulous mandible [7]. For elderly patients with
a severely resorbed mandible, the use of implants is con-
sidered a medical necessity to retain dentures adequately
and to reduce the resorption rate of the residual ridge in
the anterior mandible. But as edentulism is often con-
nected to having a low income [8], many patients cannot
afford an implant therapy with two implants.
The concept of a single median implant in an edentu-
lous mandible was introduced by Cordioli in 1993 [9] and
the first 5-year results were published in 1997 with im-
plant success rates of 100% [10]. A randomized clinical
trial with 86 edentulous patients, compared mandibular
overdentures retained by one or two implants [11]. Man-
dibular overdentures retained by a single median implant
showed comparable satisfaction and maintenance time
with lower component costs and treatment time than con-
ventional two-implant overdentures during an observation
time of 12 months. In these investigations, implants were
left unloaded during healing. In 2010, Liddelow and Henry
reported on a 100% implant-survival rate of immediately
loaded implants after 36 months of observation when
implants with oxidized surfaces were used [12]. Un-
fortunately, there was no control group with implants
following a conventional healing protocol. However,
Kronström et al. reported a failure rate of 17.6% after
12 months when immediate loading of a single median
mandibular implant was applied [6]. So results of immedi-
ate loading of a single median mandibular implant retain-
ing an overdenture are conflicting.
Therefore, the present study is designed to show that
implant success is not compromised by immediate load-
ing when a single median implant in the edentulous
mandible is used to retain a complete mandibular den-
ture. In addition it is the aim of this trial to show that
the quality of life and chewing function can be improved
earlier by immediate loading with less pain and discom-
fort for the patient.
Objectives
This clinical trial will provide scientific evidence on the suit-
ability of immediate loading of implants in an edentulousmandible. For health and economic reasons, a single me-
dian implant in the edentulous mandible is chosen as the
most cost-effective treatment having a minimal number of
implants. Approving immediate loading of a single dental
implant in an edentulous mandible will have an enormous
effect on the treatment of edentulous patients who have
insufficient function of their complete dentures. As a re-
sult of this trial, a low-cost highly effective treatment mo-
dality might be established for a large group of edentulous
patients in Germany.
Methods/design
This study was designed as a prospective multi-center ran-
domized controlled clinical trial. It will be conform to the
CONSORT statement [13]. The study was designed ac-
cording to Good Clinical Practice (GCP), the principles of
the Declaration of Helsinki (2008) and standards for pro-
fessional conduct.
A consensus for the study design, including patient treat-
ment, materials used, length and frequency of follow-up
visits, was achieved. A detailed study protocol exists. To
ensure patient safety, an independent data safety and mon-
itoring board has been installed. The study is monitored by
an independent monitor to ensure GCP guidelines. The
principal investigator approached eight additional depart-
ments of prosthetic dentistry in Germany to participate in
the trial. One department refused to participate because of
existing pressure of work. The study design was approved
by the Ethics Commission of the University Hospital
Schleswig-Holstein (processing number: AZ 138/12) as
well as the Ethics Commissions of all the other participat-
ing centers: Ethics Commission of University Hospital
Freiburg, Ethics Commission of Heidelberg University
Hospital, Ethics Commission of RWTH Aachen Univer-
sity, Ethics Commission of Ulm University Hospital,
Ethics Commission of University Hospital Hannover,
Ethics Commission of Ernst-Moritz-Arndt University of
Greifswald, Ethics Commission of the Dresden University
of Technology and the Ethics Commission of the General
Medical Council of the city of Hamburg.
Participants
Patients wishing to participate in this clinical trial have
to meet the following inclusion criteria:
– Provided written informed consent to participate in
the trial.
– Edentulous male or female patient between 60 and
89 years.
– No contraindications for implantation.
– Sufficient bone in the anterior mandible to place an
implant without augmentation procedures.
– Residual bone height is 11 to 20 mm (Class II or III
according to McGarry et al. [14]) as the lowest
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bone height in the midline of the mandible is at
least 13 mm.
– Despite technically acceptable complete dentures in
the mandible and maxilla, the patient is unsatisfied
with the retention and/or stability of the mandibular
denture while the denture in the maxilla has
adequate retention and stability.
– Existing dentures have been worn for at least
3 months to allow adaptation.
– Dentures must have a bilaterally balanced occlusal
scheme.
Patients with any of the following conditions will be
excluded:
– Edentulous patients aged 60 to 89 years with a
contraindication for implantation in the mandible
caused by systematic diseases or local bone
deficits.
– Patients satisfied with the retention of their
mandibular denture or who are unsatisfied with the
retention and/or stability of their denture in the
maxilla.
– Denture height between base and denture tooth
central anterior less than 6 mm.
– Subjects with SCL-90, German version index T-scores
of 70 or greater, or with two symptom scale scores of
70 or greater.
– Signs that the patient will be uncompliant and will
not participate fully according to the test schedule.
– Participation in any former clinical trial should have
been finished for more than 2 weeks.
Study sites
Prosthetic departments of dental schools in Germany in-
terested in clinical research were informed of the design
and the aims of this study. Nine departments decided to
participate. Each department designated an investigator
responsible for patient examinations and follow-up visits
and a clinician responsible for patient treatment (implant
placement and second-stage surgery).
Intervention
Two treatment groups are defined. For the experimental
group, the median implant is immediately loaded after
placement using a ball attachment and a matrix, which
is integrated into the existing denture base intraorally. For
the control group, the median implant is left unloaded
and allowed to heal submerged for 3 months. The implant
is loaded after second-stage surgery using a ball attach-
ment and an intraorally placed matrix.
To avoid bias, randomization is conducted after implant
placement and primary implant stability measurement byopening a sealed envelope. Neither the patient nor the
study team knows the treatment group at the time of im-
plant placement. Randomization is performed centrally by
the trial statistician using block randomization with vari-
able block size and an allocation ratio of 1:1. Stratification
is according to the patient’s residual bone height (Class II
or III according to McGarry et al. [14]) and the study
center.
All interventions are conducted according to defined
standard operating procedures. During the first calibra-
tion meeting, videos demonstrating the clinical und sur-
gical procedures are shown. These are made available to
all participating study centers. The first implant place-
ment in each center is supervised by the treatment co-
ordinator of the leading center. Experienced clinicians
perform the surgical and prosthetic procedures.
Outcomes
Implant success according to the modified success cri-
teria of Albrektsson et al. [15] has been chosen as the
primary outcome of this trial. Secondary outcomes are
the earlier improvement in quality of life and chewing
function tested using the German version of the oral
health impact questionnaire [16] and objective mastica-
tory performance [17].
It is hypothesized that patients with immediate loading
will suffer less pain and discomfort during the interven-
tion than patients with second-stage surgery as measured
by a questionnaire with a visual analog scale. Prosthetic
complications and maintenance interventions, such as ad-
justment or exchange of retention elements, fracture of
the denture base, relining and so on, are recorded and
should be comparable in both groups.
Follow-up visits will occur at 1 month and 4, 12 and
24 months after implant loading. In addition, patients in
the control group will be examined 1 month after im-
plant placement (Figure 1).
Stopping criteria
A patient will be removed from the trial if any of the fol-
lowing occur:
– Any complication during implantation.
– A minimum insertion torque of 30 Ncm
and/or a minimum implant stability quotient
of 60 is not achieved (the patient will not be
randomized and will be treated as the control
group).
– An allergic reaction to titanium.
– A serious adverse event related to the implantation.
– Any relevant deterioration in the health of the
subject possibly affecting participation in the trial.
– Failure to comply with trial requirements.
– Withdrawal of consent.
Figure 1 Organization chart of trial design.
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The success rate of a single median implant after 2 years
as the primary endpoint of the study is a binomial ran-
dom variable and success probability is assumed to be
97% in the control group as well as in the experimental
group. A maximum inferiority of 7% in the experimental
group is regarded as clinically acceptable due to the ben-
efits for these patients, i.e., avoiding the burden of a sec-
ond procedure, having a stable denture directly after
surgery and most probably reduced postoperative pain
and discomfort, since the soft tissue of the surgical wound
is not loaded with the denture during healing. Under these
assumptions, a one-sided test of binomial parameters at a
2.5% significance level has a power of 80% to reveal the
non-inferiority of the immediately loaded median im-
plant if the sample size is 148 (74 per group). Taking into
account a loss to follow-up rate of approximately 20%, a
total of 180 patients (90 per group) was considered ne-
cessary [18]. It was assumed that the reasons for loss
to follow-up would be random with respect to treat-
ment assignment.
Blinding
Due to the obvious visible differences in treatment, it is
not possible to blind the investigator or the participating
patient.
Statistical methods
For the primary outcome, the measure for non-inferiority
of the success rate of the experimental group compared tothe control group will be tested by a one-sided equiva-
lence test for the success parameter of the underlying
binomial distributions. The significance level for the
one-sided equivalence test is 2.5%. All patients that are
randomized and followed up for 24 months as well as
all patients with an implant failure will be statistically
analyzed. The secondary endpoints (improvement of the
chewing efficiency and improvement of the oral health
related quality of life after the intervention) will be ad-
dressed by non-parametric tests for non-inferiority of the
experimental group compared to the control group. Non-
inferiority of prosthetic complications will be analyzed by
one-sided equivalence tests.
In the case of an implant failure in the experimental
group, the patient will be treated according to the proto-
col of the control group with a new implant. Those pa-
tients will be excluded from the trial before retreatment.
If more than 20% of the implants fail in any group
within the first 3 months after implant placement, the
study will be terminated. This criterion will be checked
every 6 months after the inclusion of the first patient.
Recruitment
Recruitment of patients will be performed in two steps.
Edentulous patients who have signed the informed con-
sent will be screened according to the inclusion and
exclusion criteria applying standardized examination
forms and questionnaires including the SCL-90-index.
Patients who otherwise meet the inclusion criteria but
whose complete dentures are judged not to be technically
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dentures. They will be offered the opportunity to be exam-
ined again after these improvements to the denture for
possible inclusion in the trial if the dentures can be worn
for at least 3 months before the recruitment period ends.
Patients meeting the inclusion criteria regarding den-
ture status, denture satisfaction and SCL-90-index will
undergo a radiographic examination (panoramic x-ray
with reference marker) to determine whether the re-
sidual bone height of the mandible meets the inclusion
criteria. To achieve consistent evaluation of the x-rays,
the trial coordinator will assess all x-rays from each pa-
tient and perform the required measurements. For qual-
ity assurance, each patient’s documents will be sent
pseudonymized to the treatment coordinator, who will
make the final decision on inclusion in the study. If all
inclusion criteria are met, patients will be included in
the study.
Discussion
This randomized clinical trial is designed to show the
suitability of immediate loading of single median im-
plants in an edentulous mandible. It is hypothesized that
there will be non-inferiority of implant success for the
experimental group compared to the control group.
Present clinical trials investigating a single midline im-
plant in an edentulous mandible are mostly designed
with a small number of patients [6,19,20]. Due to the
sample size required for our clinical trial, a multi-center
design is necessary. Taking into account a loss to follow-
up rate of approximately 20%, a total of 180 patients (90
per group) was considered necessary. The loss to follow-
up rate of 20% appears rather conservative but this rate
also takes into account the exclusion of patients due to
stopping criteria, e.g. compromised implant stability. In
one study on immediate loading of a single mandibular
implant, only 1 out of 17 implants (5.9%) did not achieve
a minimum insertion torque of 30 Ncm [6]. In another
study of immediate loading, only 2 out of 27 implants
(7.4%) with oxidized surfaces did not achieve an inser-
tion torque of 45 Ncm; however, the insertion torque
actually obtained for these two implants was not re-
ported [20]. From these studies, it is assumed that in our
trial the number of patients excluded due to compro-
mised implant stability and loss to follow-up will be less
than 20%.
In a pilot study conducted at the University of Kiel, 11
patients were treated with one median implant in the man-
dible [21,22]. During this pilot trial, six implants followed a
non-submerged healing protocol and were provided with a
healing abutment and thus loaded moderately. No implant
failed. The initial idea for the present clinical trial was to
design a third treatment group as another experimental
group with implants healing unsubmerged and moderatelyloaded over the healing abutment. However, for this three-
arm study design, 354 patients would need to be allocated
to the trial, as 282 patients would be needed for analysis.
This number of patients would not have been feasible, es-
pecially in terms of finance. The idea of the present clinical
trial is to compare two different healing protocols and not
two different treatment options. The non-inferiority of one
versus two implants in an edentulous mandible was shown
by Walton et al. in 2009 [11]. A third treatment group with
two implants in the interforaminal area was thus not con-
sidered necessary.
The defined inclusion criteria seem to be rather con-
servative, especially in terms of the residual bone height.
We decided to include patients measured as McGarry
Class II and III only. Patients with a residual bone height
of 10 mm or less as the lowest vertical height of the
mandible (Class IV) are excluded due to the risk of a ro-
tational axis in the implant area and insufficient bone
support of the mandibular overdenture in the posterior
region. Patients with a residual bone height of 21 mm or
greater as the lowest vertical height of the mandible
(Class I) are excluded as well. It was expected that those
patients’ quality of life related to oral health and pros-
thodontic satisfaction would already be at a rather high
level and would not be significantly improved with an
implant therapy requiring surgical intervention. It was
estimated that 230 people assessed for eligibility would
result in 180 people being allocated to the trial (an ex-
clusion rate of 21.7%). So far, 19.1% of patients who have
undergone screening have had to be excluded due to in-
sufficient bone according to McGarry [14]. The residual
bone height seems to be a major factor when considering
edentulous patients for implant therapy. Psychological fac-
tors were of minor importance. Due to the high exclusion
rate after screening during the first 8 months of recruit-
ment, the recruitment period was extended until March
2014.
Trial status
At the time of submission of this paper, patient recruit-
ment is still ongoing. Patients will be enrolled in the trial
until the end of March 2014. Recruitment will be stopped
automatically as soon as 180 patients have been included.
Abbreviation
GCP: good clinical practice.
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